Key result
Incidental Aschoff bodies at cardiac surgery linked to ~4-fold higher 10-year mortality.
Why the study?
Rheumatic heart disease is neglected and underdiagnosed, with no completely reliable specific laboratory diagnostic test.
Does the presence of Aschoff bodies in surgical biopsies predict long-term mortality in patients undergoing heart surgery for rheumatic heart disease?
Observational (n=118)
No
Does the presence of Aschoff bodies in surgical biopsies predict long-term mortality in patients undergoing heart surgery for rheumatic heart disease?
The incidental finding of Aschoff bodies in surgical biopsies from patients with rheumatic heart disease is associated with significantly increased long-term mortality.
Answers are grounded in this paper and cite their sources.
May signal higher late mortality risk after RHD surgery; hypothesis-generating and should not yet change practice.
Rheumatic fever (RF) and rheumatic heart disease (RHD) are still highly prevalent, particularly in low- and middle-income countries. RHD is a neglected and underdiagnosed disease for which no specific laboratory diagnostic test is completely reliable. This is a retrospective observational study, which included 118 patients with RHD who underwent cardiac surgery from 1985 to 2018. The aim of this investigation was to evaluate the clinical, epidemiological, echocardiographic and pathological characteristics in two cohorts of RHD patients: one cohort with Aschoff bodies present in their pathological results and the other without such histopathological characteristics. No conventional clinical and laboratory tests for RHD myocarditis were able to identify active carditis during the preoperative phase of valve repair or replacement. Patients who had Aschoff bodies in their pathological results were younger (median age of 13 years (11–24 years) vs. 27 years (17–37 years), p = 0.001) and had higher rate of late mortality (22.9% vs. 5.4%, p = 0.043). In conclusion, the presence of Aschoff bodies in pathological findings may predict increased long-term mortality, emphasizing the importance of comprehensive pathology analysis for suspected myocarditis during heart surgery.
No takes yet. Share an insight, caveat, or question.
Vieira et al. (2023) conducted an observational in Rheumatic heart disease (n=118). Presence of Aschoff bodies in surgical biopsy vs. Absence of Aschoff bodies was evaluated on Late mortality (p=0.043). The incidental finding of Aschoff bodies in myocardial and valvular biopsies during cardiac surgery predicted increased late mortality (22.9% vs 5.4%) over a 10-year follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: